Meaningful measures in cancer cachexia: implications for practice and research

Area of Science:

• Oncology
• Internal Medicine
• Clinical Assessment

Background:

• Cancer cachexia is a complex inflammatory syndrome with diverse symptoms.
• Accurate recognition and assessment pose challenges for clinicians and researchers.

Purpose of the Study:

• To review the evidence for various measures used in assessing cancer cachexia.
• To explore objective and clinical assessment tools for cachexia.

Main Methods:

• Review of evidence for CT-derived measures (skeletal muscle index, skeletal muscle density).
• Examination of inflammatory markers (IL-1α, IL-1β, IL-6, IFNγ).
• Evaluation of performance status, modified Glasgow prognostic score, and clinical functional tests (hand grip strength, calf circumference, gait speed, timed up and go test).
• Inclusion of patient-reported quality-of-life measures (EORTC QLQ-C30).

Main Results:

• CT-derived skeletal muscle density (SMD) may be more valuable than skeletal muscle index (SMI).
• Inflammatory markers and performance status are robust but primarily used in academia.
• Clinical assessments are less evidenced but more commonly used in practice.
• Patient-reported outcomes also show utility in cachexia assessment.

Conclusions:

• Further research is needed to compare clinical measures of cachexia.
• Determining the utility of various assessment tools is crucial for improved patient care.